01 Scan
Review available market data and group contracts by their underlying event.
Review available market data and group contracts by their underlying event.
Prioritize evidence, resolution clarity, probability, timing and economics.
A human analyst challenges the thesis, downside and resolution rules.
Publish approved research with a side, reference entry, sources and key risk.
Equivalent contracts. Strongest economics after costs.
Challenge unclear rules and fragile evidence. Liquidity is context, not a hard veto.
Independent event types rather than stacked risk.
This page describes the agreed research framework, not a claim that every automated pipeline stage or provider connection is live. The product reads existing published records and the immutable registry. Automated catalog coverage, scoring runs and provider health are not verified by this interface. Quotes are checked manually on demand after preselection; there is no automatic trading or publication.
Assess independent citations, publication timestamps and exact settlement rules for each record. Verify eligibility directly with a venue: U.S. availability, geographic restrictions, account requirements and contract terms vary. Third-party references are not endorsements or proof of an API partnership.
We publish nothing when nothing qualifies.
Up to 30 active signals across independent niches. If nothing qualifies, capacity stays unused.
Research only. We never custody funds or execute trades. Diversification does not eliminate losses.
Official tracking begins Nov. 11, 2026 under PA-Core-v1. Only immutable forward publications count; open signals are not realized gains, and every official published loss remains visible.